Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

However, stopping beta-blocker medication was only associated with a higher risk in patients whose heart function had only ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

WEDNESDAY, March 26, 2025 (HealthDay News) — In patients with heart failure with improved ejection fraction (EF), pharmacological therapy is rarely withdrawn, according to a study published online ...

The largest randomized study of fluid intake restrictions showed no benefit from the restrictions, according to its senior ...

4 • The person cannot do any kind of activity ... Though there is no known cure, early diagnosis and treatment of heart failure symptoms are essential for managing the condition and extending ...

The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...